Reklāma
Forex ziņas
Beyond Appoints Marcus Lemonis As Executive Chairman
Beyond, Inc. (BYON), owner of Bed Bath & Beyond, Overstock.com, and other online retail brands, announced Tuesday that it appointed Marcus Lemonis as Executive Chairman of the board of directors, effective today.
RTTNews |
555 days ago
Syngenta Crop, Lavie Bio Partner To Discover And Develop New Biological Insecticidal Solutions
Swiss agricultural innovation firm Syngenta Crop Protection and Israel's Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (EVGN), announced Tuesday an agreement for the discovery and development of new biological insecticidal solutions.
RTTNews
|
555 days ago
Walmart To Acquire VIZIO HOLDING For $11.50/Shr Cash
Walmart, Inc. (WMT) and VIZIO Holding Corp. (VZIO) announced Tuesday they have entered into an agreement for Walmart to acquire VIZIO for $11.50 per share in cash, equating to a fully diluted equity value of approximately $2.3 billion.
RTTNews
|
555 days ago
Earnings Boost Lifts CAC-40
The CAC-40 gained further on Tuesday amidst strong corporate results announcement. However lingering anxiety ahead of the release of the ECB minutes limited gains.
RTTNews
|
555 days ago
Walmart Guides FY25 Adj. EPS Above Estimates; Boosts Dividend 9% - Update
While reporting financial results for the fourth quarter on Tuesday, retail giant Walmart, Inc. (WMT) initiated its adjusted earnings and net sales growth guidance for the first quarter and the full-year 2025.
RTTNews
|
555 days ago
Medtronic Boosts FY24 Outlook - Update
While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) raised its adjusted earnings and organic revenue growth guidance for the full-year 2024, based on third quarter performance.
RTTNews
|
555 days ago
Allete Q4 Results Miss Estimates
Energy utility Allete Inc. (ALE) reported Tuesday that net income attributable to ALLETE for the fourth quarter edged down to $51.5 million or $0.89 per share from $51.7 million or $0.90 per share in the prior-year quarter.
RTTNews
|
555 days ago
more news
DAX Weak As Markets Brace For ECB Minutes, Key Data Releases
Germany's DAX benchmark witnessed weak sentiment as markets braced for the release of the ECB minutes as well as PMI, GDP and Business Climate readings later in the week.
RTTNews
|
555 days ago
IDEAYA Biosciences Q4 Results Misses Estimates
IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews
|
555 days ago
Barclays Posts Q4 Loss, Plans GBP 2 Bln Cost Actions, To Return GBP 10 Bln; Stock Up
Shares of Barclays Plc were gaining more than 6 percent on London stock exchange as well as around 8 percent in pre-market activity on the NYSE after the British lender announced a new 2 billion pounds, three-year cost efficiency savings plan, as well as its plan to return 10 billion pounds of capital to shareholders. Meanwhile, the company reported sharply lower pre-tax profit in its fourth quart
RTTNews
|
555 days ago
Truist Financial To Sell Remaining Stake In Truist Insurance Holdings
Truist Financial Corp. (TFC) announced Tuesday that it has reached a definitive agreement to sell its remaining stake in Truist Insurance Holdings, a subsidiary of Truist and the fifth largest insurance brokerage in the U.S., to an investor group led by private equity firms Stone Point Capital and Clayton, Dubilier & Rice. Mubadala Investment Company and other co-investors are also participating in the investment.
RTTNews
|
555 days ago
China's Rate Cut Fails To Lift Asian Market Sentiment
The People's Bank of China cutting its 5-year loan prime rate by 25 basis points, far more than by 15 basis points that the markets were expecting, failed to revive market sentiment in the Asian bourses.
RTTNews
|
555 days ago
It's A First; Cellular Therapy For Melanoma And Drug To Reduce Food Allergic Reactions Get FDA Nod
Latest approvals by the U.S. Food and Drug Administration include Iovance Biotherapeutics Inc.'s Amtagvi - the first cellular therapy indicated for the treatment of unresectable or metastatic melanoma, as well as Genentech's Xolair- the first medication to help reduce allergic reactions to multiple foods after accidental exposure.
RTTNews
|
555 days ago
Stay up to date!
Add Ziņas to your browser
Add To Chrome
